BusinessEisai Revenue Reaches ¥470 Billion With Operating Profit Up 20.4%By Helena WardNov 11, 2026, 12:18 PM UTC
HealthEisai Plans Five-Year Lecanemab Findings and Clinic Studies at CTADBy Naomi CalderOct 30, 2026, 7:31 AM UTC
HealthEisai Schedules Oct. 25 Kidney Cancer Trial Analyses for ESMO CongressBy Naomi CalderOct 15, 2026, 3:52 PM UTC
